Libtayo Եվրոպական Միություն - խորվաթերեն - EMA (European Medicines Agency)

libtayo

regeneron ireland designated activity company (dac) - cemiplimab - karcinom, squamous cell - antineoplastična sredstva - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Teysuno Եվրոպական Միություն - խորվաթերեն - EMA (European Medicines Agency)

teysuno

nordic group b.v. - тегафур, gimeracil, oteracil - neoplazme želuca - antineoplastična sredstva - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Lidokainklorid B. Braun 20 mg/ml otopina za injekciju/infuziju Խորվաթիա - խորվաթերեն - HALMED (Agencija za lijekove i medicinske proizvode)

lidokainklorid b. braun 20 mg/ml otopina za injekciju/infuziju

b. braun adria d.o.o., hondlova 2/9, zagreb, hrvatska - lidokainklorid - otopina za injekciju / infuziju - 20 mg/ml - urbroj: 1 ml otopine za injekciju/infuziju sadrži 20 mg lidokainklorida

GRIESHABER ADVANCED DSP TIPS Խորվաթիա - խորվաթերեն - HALMED (Agencija za lijekove i medicinske proizvode)

grieshaber advanced dsp tips

alcon farmaceutika d.o.o., zagreb - ručni mikroinstrumenti (pincete i škarice) za operacije prednjeg i stražnjeg segmenta oka

TECNIS MULTIFOCAL ACRYLIC ZMA00 I TECNIS 1-PIECE LENS ZCB00 Խորվաթիա - խորվաթերեն - HALMED (Agencija za lijekove i medicinske proizvode)

tecnis multifocal acrylic zma00 i tecnis 1-piece lens zcb00

oktal pharma d.o.o., zagreb - multifokalne akrilatne intraokularne leće za ugradnju u stražnju sobicu oka i jednodjelne akrilatne intraokularne leće